Genmab

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genmab and other ETFs, options, and stocks.

About GMAB

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. 

CEO
Jan G. J. van de Winkel
CEOJan G. J. van de Winkel
Employees
3,029
Employees3,029
Headquarters
Copenhagen, Central Denmark
HeadquartersCopenhagen, Central Denmark
Founded
1998
Founded1998
Employees
3,029
Employees3,029

GMAB Key Statistics

Market cap
31.95B
Market cap31.95B
Price-Earnings ratio
43.62
Price-Earnings ratio43.62
Dividend yield
—
Dividend yield—
Average volume
4.55M
Average volume4.55M
High today
$52.82
High today$52.82
Low today
$51.51
Low today$51.51
Open price
$52.65
Open price$52.65
Volume
2.41M
Volume2.41M
52 Week high
$59.97
52 Week high$59.97
52 Week low
$23.62
52 Week low$23.62

GMAB News

Simply Wall St 2d
We Think You Can Look Beyond Genmab's Lackluster Earnings - Simply Wall St

...

We Think You Can Look Beyond Genmab's Lackluster Earnings - Simply Wall St
TipRanks 4d
Genmab Reports Share Sales by Two Board Members

Genmab ( (GMAB) ) has provided an update. On November 12, 2026, Genmab reported that board members Martin Schultz and Mijke Zachariasse sold 617 and 351 Genmab...

TipRanks 4d
Genmab Files Articles of Association Dated November 10

Genmab ( (GMAB) ) has shared an announcement. Genmab A/S is engaged in medical research, production and sale of related products, and related business. Its Art...

Analyst ratings

81%

of 26 ratings
Buy
80.8%
Hold
11.5%
Sell
7.7%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.